CiVi Biopharma
Christopher Fuglesang is Co-Founder and Managing Director of Boxer Capital, LLC. After joining Tavistock Group in 2005, Dr. Fuglesang helped scale Tavistock Group’s public healthcare investing activities with Boxer Capital. Dr. Fuglesang assists in managing the firm’s research team, deal structuring, and securities compliance.
In addition to CiVi Biopharma, Dr. Fuglesang serves as a Board Observer of Passage Bio and Pandion Therapeutics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices